Clinical Trial Update: Trial on the Efficacy and Safety of Two Different Glucocorticoid Dose Regimens in Allergic Bronchopulmonary Aspergillosis [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial evaluated two glucocorticoid dose regimens in patients with Allergic bronchopulmonary aspergillosis to assess efficacy and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Bronchopulmonary Aspergillosis

Drugs mentioned

• glucocorticoid therapy (two dosing regimens)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Allergic Bronchopulmonary Aspergillosis | Phase 2, Phase 3 | Status: COMPLETED